Pre-existing Antibody: Biotherapeutic Modality-Based Review.
about
Preexisting Antibodies to an F(ab')2 Antibody Therapeutic and Novel Method for Immunogenicity Assessment.Immunogenicity considerations for antibody-drug conjugates: a focus on neutralizing antibody assays.Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin.LC-MS quantification of protein drugs: validating protein LC-MS methods with predigestion immunocapture.
P2860
Pre-existing Antibody: Biotherapeutic Modality-Based Review.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pre-existing Antibody: Biotherapeutic Modality-Based Review.
@ast
Pre-existing Antibody: Biotherapeutic Modality-Based Review.
@en
type
label
Pre-existing Antibody: Biotherapeutic Modality-Based Review.
@ast
Pre-existing Antibody: Biotherapeutic Modality-Based Review.
@en
prefLabel
Pre-existing Antibody: Biotherapeutic Modality-Based Review.
@ast
Pre-existing Antibody: Biotherapeutic Modality-Based Review.
@en
P2093
P2860
P1433
P1476
Pre-existing Antibody: Biotherapeutic Modality-Based Review
@en
P2093
Adrienne Clements-Egan
Crystal Sung
Heather Myler
Laura Salazar-Fontana
Manoj Rajadhyaksha
Mary Birchler
Meina Liang
Shobha Purushothama
P2860
P2888
P304
P356
10.1208/S12248-016-9878-1
P407
P577
2016-01-28T00:00:00Z
P6179
1004880847